Physician profile
Shanda W Sandridge
NPI 1144527292
$1,100.44
in general payments reported to CMS, 2019-2025
9 companies · $262 in 2025
The $262 reported for 2025 was more than what 86% of Pediatrics, Critical Care providers received nationally (typical 2025 total: $80.91).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $333 · 2022: $213 · 2023: $118 · 2024: $175 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $508.46 | 2021-2025 | Wegovy, Saxenda |
| Rhythm Pharmaceuticals, INC. | $179.91 | 2022-2024 | Imcivree |
| Takeda Pharmaceuticals U.S.A., INC. | $119.38 | 2021-2023 | Gattex |
| Neurelis, INC. | $91.95 | 2023 | Valtoco |
| Soleno Therapeutics, INC. | $62.49 | 2025 | Vykat Xr |
| Abbvie INC. | $51.15 | 2021-2022 | |
| Lilly USA, LLC | $45.49 | 2025 | Zepbound, Mounjaro |
| Acorda Therapeutics, INC | $26.10 | 2021-2022 | |
| Medtronic, INC. | $15.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shanda Sandridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.